Those of you following preemption in generic drug cases will be interested to note that the Mensing case, where the Court asked the SG for the government’s views on the subject, was relisted for the Court’s 21/15 conference, after having originally been considered last Friday.  How do we know?  Well, if SCOTUSBlog says it, it must be true.

Stay tuned.